Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure : a prediction model

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..

AIMS: Management of patients with atrial fibrillation (AF) and concomitant heart failure (HF) remains complex. The Antwerp score, based on four parameters [QRS >120 ms (2 points), known aetiology (2 points), paroxysmal AF (1 point), severe atrial dilation (1 point)] adequately estimated the probability of left ventricular ejection fraction (LVEF) recovery after AF ablation in a single-centre cohort. The present study aims to externally validate this prediction model in a large European multi-centre cohort.

METHODS AND RESULTS: A total of 605 patients (61.1 ± 9.4 years, 23.8% females, 79.8% with persistent AF) with HF and impaired LVEF (<50%) undergoing AF ablation in 8 European centres were retrospectively identified. According to the LVEF changes at 12-month echocardiography, 427 (70%) patients fulfilled the '2021 Universal Definition of HF' criteria for LVEF recovery and were defined as 'responders'. External validation of the score yielded good discrimination and calibration {area under the curve 0.86 [95% confidence interval (CI) 0.82-0.89], P < .001; Hosmer-Lemeshow P = .29}. Patients with a score < 2 had a 93% probability of LVEF recovery as opposed to only 24% in patients with a score > 3. Responders experienced more often positive ventricular remodelling [odds ratio (OR) 8.91, 95% CI 4.45-17.84, P < .001], fewer HF hospitalizations (OR 0.09, 95% CI 0.05-0.18, P < .001) and lower mortality (OR 0.11, 95% CI 0.04-0.31, P < .001).

CONCLUSION: In this multi-centre study, a simple four-parameter score predicted LVEF recovery after AF ablation in patients with HF and discriminated clinical outcomes. These findings support the use of the Antwerp score to standardize shared decision-making regarding AF ablation referral in future clinical studies.

Errataetall:

CommentIn: Eur Heart J. 2023 Sep 14;44(35):3336-3338. - PMID 37387669

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:44

Enthalten in:

European heart journal - 44(2023), 35 vom: 14. Sept., Seite 3327-3335

Sprache:

Englisch

Beteiligte Personen:

Bergonti, Marco [VerfasserIn]
Ascione, Ciro [VerfasserIn]
Marcon, Lorenzo [VerfasserIn]
Pambrun, Thomas [VerfasserIn]
Della Rocca, Domenico G [VerfasserIn]
Ferrero, Teba Gonzalez [VerfasserIn]
Pannone, Luigi [VerfasserIn]
Kühne, Michael [VerfasserIn]
Compagnucci, Paolo [VerfasserIn]
Bonomi, Alice [VerfasserIn]
Gevaert, Andreas B [VerfasserIn]
Anselmino, Matteo [VerfasserIn]
Casella, Michela [VerfasserIn]
Krisai, Philipp [VerfasserIn]
Tondo, Claudio [VerfasserIn]
Rodríguez-Mañero, Moises [VerfasserIn]
Derval, Nicolas [VerfasserIn]
Chierchia, Gian-Battista [VerfasserIn]
de Asmundis, Carlo [VerfasserIn]
Heidbuchel, Hein [VerfasserIn]
Jaïs, Pierre [VerfasserIn]
Sarkozy, Andrea [VerfasserIn]

Links:

Volltext

Themen:

AF ablation
Atrial fibrillation
Heart failure
Journal Article
Multicenter Study
Pulmonary vein isolation
Recovery
Reduced ejection fraction
Score

Anmerkungen:

Date Completed 15.09.2023

Date Revised 18.09.2023

published: Print

CommentIn: Eur Heart J. 2023 Sep 14;44(35):3336-3338. - PMID 37387669

Citation Status MEDLINE

doi:

10.1093/eurheartj/ehad428

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM358889421